We are live on
!
Find out more
EGM
Engineers Gate Manager Portfolio holdings
AUM
$8B
1-Year Est. Return
17.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.58%
1 Year Est. Return
+17.32%
3 Year Est. Return
+34.79%
5 Year Est. Return
+1.56%
10 Year Est. Return
+206.65%
AUM
$5.75B
AUM Growth
+$622M
(+12%)
Cap. Flow
+$721M
Cap. Flow
% of AUM
12.55%
Top 10 Holdings %
Top 10 Hldgs %
7.33%
Holding
2,680
New
612
Increased
791
Reduced
767
Closed
502
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$99.9M |
| 2 |
CVS Health
CVS
|
+$41.2M |
| 3 |
Uber
UBER
|
+$32.8M |
| 4 |
Medtronic
MDT
|
+$25.1M |
| 5 |
Booking.com
BKNG
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$23.5M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$21.2M |
| 3 |
Micron Technology
MU
|
+$20.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$19.4M |
| 5 |
Chevron
CVX
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.9% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Industrials | 14.79% |
| 4 | Healthcare | 12.41% |
| 5 | Financials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Black Diamond Therapeutics
BDTX
$101M
| $23.8K | ﹤0.01% |
11,143
-7,268
| -39% | -$20.8K |
|
|
RPTX
2152
DELISTED
Repare Therapeutics
RPTX
| $23.7K | ﹤0.01% |
18,122
+6,733
| +59% | +$20.1K |
|
|
VIGL
2153
DELISTED
Vigil Neuroscience
VIGL
| $23.3K | ﹤0.01% |
+13,695
| New | +$40.4K |
|
2154
Solarmax Technology
SMXT
$19.4M
| $21.7K | ﹤0.01% |
+13,378
| New | +$15.9K |
|
2155
Galectin Therapeutics
GALT
$229M
| $21.3K | ﹤0.01% |
+16,491
| New | +$39.5K |
|
|
TGB
2156
Trekor Metals
TGB
$2.56B
| $20.4K | ﹤0.01% |
10,493
-34,117
| -76% | -$75.2K |
|
2157
Babcock & Wilcox
BW
$1.43B
| $19.9K | ﹤0.01% |
12,119
-47,411
| -80% | -$100K |
|
2158
Tempest Therapeutics
TPST
$14.8M
| $19.6K | ﹤0.01% |
+1,807
| New | +$23.3K |
|
2159
Karyopharm Therapeutics
KPTI
$168M
| $19.4K | ﹤0.01% |
1,913
-1,296
| -40% | -$15.7K |
|
2160
Caribou Biosciences
CRBU
$156M
| $18K | ﹤0.01% |
+11,294
| New | +$22.7K |
|
|
QMMM
2161
QMMM Holdings
QMMM
| $17.6K | ﹤0.01% |
+13,758
| New | +$71K |
|
|
ZDAI
2162
DirectBooking Technology Co
ZDAI
$13.6M
| $17.3K | ﹤0.01% |
+766
| New | +$127K |
|
2163
NextCure
NXTC
$17.3M
| $15.6K | ﹤0.01% |
1,683
+785
| +87% | +$11.5K |
|
2164
Ocugen
OCGN
$410M
| $15.2K | ﹤0.01% |
+18,851
| New | +$17.3K |
|
|
ORGN
2165
DELISTED
Origin Materials
ORGN
| $14.5K | ﹤0.01% |
+379
| New | +$14.4K |
|
|
BNKK
2166
Bonk Inc
BNKK
$8.96M
| $13.3K | ﹤0.01% |
+527
| New | +$18.2K |
|
2167
Veru
VERU
$36.1M
| $12.9K | ﹤0.01% |
1,983
-535
| -21% | -$3.97K |
|
|
PRPH
2168
DELISTED
ProPhase Labs
PRPH
| $12.1K | ﹤0.01% |
+1,597
| New | +$22.4K |
|
2169
Verrica Pharmaceuticals
VRCA
$86.2M
| $10.8K | ﹤0.01% |
1,538
-124
| -7% | -$1.36K |
|
|
LONA
2170
LeonaBio Inc
LONA
$69.4M
| $9.66K | ﹤0.01% |
1,646
-1
| -0.1% | -$6 |
|
|
MRNS
2171
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.57K | ﹤0.01% |
16,023
-13,459
| -46% | -$9.38K |
|
|
CMLS
2172
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $8K | ﹤0.01% |
11,940
| – | – |
|
2173
5E Advanced Materials
FEAM
$47.7M
| $7.78K | ﹤0.01% |
528
| – | – |
|
2174
BioAtla
BCAB
$5.59M
| $7.58K | ﹤0.01% |
+256
| New | +$21.5K |
|
|
KLRS
2175
Kalaris Therapeutics
KLRS
$88.7M
| $6.77K | ﹤0.01% |
701
+245
| +54% | +$3.71K |
|
Similar funds
SI
MT
CMTU
FMI
MAM
VIM
FIA
AIM
Engineers Gate Manager's Q4 2024 Portfolio in Review
As of Q4 2024, Engineers Gate Manager held 2,680 positions worth $5.75B, up 12% from $5.12B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
Engineers Gate Manager deployed $721M of net new capital in Q4 2024, opening 612 new positions and adding to 791 existing holdings. Its largest new stake was CVS Health: 734,079 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Costco, an estimated $23.5M trimmed.
- Engineers Gate Manager's largest Q4 2024 buy was CVS Health: 734,079 shares worth $33M.
- Engineers Gate Manager added most to Invesco QQQ Trust in Q4 2024, an estimated $99.9M increase.
- Engineers Gate Manager's biggest Q4 2024 reduction was Costco, cutting an estimated $23.5M.
- Engineers Gate Manager fully exited PACCAR in Q4 2024, selling an estimated $17.9M.
- Engineers Gate Manager's ten largest holdings make up 7.3% of its $5.75B portfolio in Q4 2024.
- Engineers Gate Manager opened 612 new positions and closed 502 in Q4 2024.
- Engineers Gate Manager's portfolio value rose 12% quarter-over-quarter to $5.75B.
Based on Engineers Gate Manager's 13F filing for Q4 2024, filed 14 Feb 2025.